Michelle Renee Griffin - Jun 4, 2021 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Stock symbol
KDNY
Transactions as of
Jun 4, 2021
Transactions value $
$0
Form type
4
Date filed
6/7/2021, 09:35 PM
Previous filing
May 19, 2021
Next filing
Jun 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Stock Option (Right to Buy) Award $0 +5.95K $0.00 5.95K Jun 4, 2021 Common Stock 5.95K $16.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award will fully vest upon the earlier of 1) the Issuer's next annual stockholder meeting, or 2) June 4, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.